HeartBeam (BEAT) Portable ECG Technology FAQ

What is HeartBeam developing?

HeartBeam is creating a portable, credit-card-sized device and proprietary software that captures heart signals in three non-coplanar dimensions and reconstructs them into a full synthesized 12-lead ECG.

Why is this technology significant for cardiac care?

This innovation is important because it combines portability with medical-grade accuracy, potentially enabling earlier intervention for heart disease, reducing hospitalizations, and providing faster responses to arrhythmias outside traditional medical facilities.

How does the HeartBeam ECG system work?

The system captures the heart’s electrical signals from three dimensions using portable devices and reconstructs those signals into a full synthesized 12-lead ECG through proprietary software, making it the first cable-free 12-lead ECG solution.

What validation supports this technology?

The VALID-ECG study results validate the technology and carry significant weight for both clinical adoption and HeartBeam’s commercialization pathway, according to the featured article.

When is HeartBeam planning to commercialize this technology?

The article mentions upcoming commercialization of its ECG system, though no specific timeline is provided in the content.

Where can this technology be used?

The portable devices can be used wherever the patient is, allowing cardiac monitoring and diagnosis outside of medical facilities, thus redefining remote cardiac health management.

What are the potential benefits for patients and physicians?

Physicians can identify cardiac health trends and acute conditions remotely, while patients benefit from earlier intervention, fewer hospitalizations, and faster responses to arrhythmias through actionable heart intelligence delivered outside medical facilities.

What intellectual property does HeartBeam hold?

The company holds 13 U.S. and 4 international-issued patents related to technology enablement for their cardiac monitoring platform.

How can I learn more about HeartBeam?

For more information, visit www.HeartBeam.com or view the full article at https://ibn.fm/bD5II.

What should investors know about forward-looking statements in this content?

The article contains forward-looking statements subject to risks and uncertainties, and investors should not place undue reliance on them, referring instead to the company’s SEC filings for comprehensive risk factors.